Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
05.03. | Borussia Dortmund - A more normal schedule | 247 | Borussia Dortmund's Q224 results reflect the positive effects of a more normal football season versus the disruption from the FIFA World Cup in the comparative Q223 period. The reiterated financial... ► Artikel lesen | ||
04.03. | Creo Medical - MicroBlate Flex progresses with first robotics use | 205 | Creo Medical has marked another milestone in advancing utility of its electrosurgical devices with the first use of its MicroBlate Flex device in a robotic-guided lung tissue ablation procedure (as... ► Artikel lesen | ||
04.03. | Ultimovacs - Peer-reviewed publication reiterates UV1's potential | 196 | Ultimovacs' results from the Phase II NIPU trial for its universal, off-the-shelf cancer vaccine UV1 in second-line metastatic pleural mesothelioma (MPM) have been published in the European Journal... ► Artikel lesen | ||
04.03. | abrdn Private Equity Opportunities Trust - Returns and buyback help narrow the discount | 147 | abrdn Private Equity Opportunities Trust (APEO) achieved a 5.4% NAV total return (TR) in FY23 (to end-September 2023) despite muted private equity (PE) deal activity and foreign exchange headwinds (its... ► Artikel lesen | ||
04.03. | UIL - Long-term focus, avoiding short-term noise | 110 | UIL Limited (UIL) is managed by Charles Jillings and his highly experienced team at value-based specialist investor ICM. It is a unique portfolio of undervalued assets, which is illustrated by the fund's... ► Artikel lesen | ||
04.03. | AAC Clyde Space - Strong order backlog underpins growth prospects | 136 | In FY23, AAC was largely affected by continuing supplier delays, which compromised the anticipated delivery of subsystems and delayed projects, with subsequent key revenue deferred. Nevertheless, Q423... ► Artikel lesen | ||
04.03. | AGBA - US$5m placement at a premium | 232 | On 15 February AGBA announced term sheets have been executed on a US$5.1m private placement of ordinary shares plus warrants to an institutional investor and AGBA's group president and management. The... ► Artikel lesen | ||
04.03. | MGI - Media and Games Invest - Back on a growth track | 330 | MGI - Media and Games Invest (MGI) had a good Q423, gaining market share in an improving trading environment. Organic revenue growth of 16% in the quarter helped lift the full year figure to +5%. This... ► Artikel lesen | ||
04.03. | 4iG - Record FY23 results; transformation plan underway | 195 | 4iG's FY23 results showed good revenue and EBITDA growth on a reported and pro forma basis. The Telco business, which includes an 11 month contribution from the Vodafone Hungary acquisition, showed... ► Artikel lesen | ||
01.03. | Regional REIT - Lancing the boil? | 159 | Regional REIT (RGL) has declared an unchanged Q423 DPS of 1.2p per share and is making good progress with asset sales. However, with H223 property valuations following the market lower, and a subsequent... ► Artikel lesen | ||
01.03. | Scandic Hotels Group - Tender indeed is the North | 260 | Newly confirmed strong finances (just 0.6x net debt/adjusted EBITDA including convertible loan) and continued Nordic market resilience, allied with multiple growth initiatives, are justifiably reinforcing... ► Artikel lesen | ||
01.03. | Dar Global - Initial FY23 results exceed revised guidance | 197 | Dar Global's FY23 results showed impressive growth driven by a range of positive factors, which bodes well for 2024 and beyond. Dar Global is in the early stages of delivering over 5,700 residences... ► Artikel lesen | ||
01.03. | SenSen Networks - Clear path to sustainable cash generation | 194 | In H124 SenSen delivered positive free cash flow for the first time, a key milestone. The group's Smart Cities focus and standardised business model supported steady top-line progression, as well as... ► Artikel lesen | ||
29.02. | Nano Dimension - Share buyback underway | 231 | Nano Dimension has provided a business update that highlights a major R&D milestone, a system sale to a defence customer and the start of a $200m share buyback programme. Management is focused on optimising... ► Artikel lesen | ||
29.02. | Good Life Plus - Welcome to the Goodlife! | 86 | Good Life Plus (GL+) is an early-stage, entertainment-focused, subscription-based prize draw operator. Based in the UK, the business was founded in 2021. The majority of GL+'s members pay a subscription... ► Artikel lesen | ||
29.02. | S&U - Impairments drag FY24 PBT, moderation in FY25 | 151 | In its trading update between December 2023 and January 2024, S&U announced that FY24 PBT will be 10% to 15% below consensus of c £38m. The key reason is lower collection rates in Advantage of 90% (H123:... ► Artikel lesen | ||
29.02. | The Law Debenture Corporation - One plus one equals three | 149 | FY23 results for The Law Debenture Corporation (LWDB) show this well-proven, rare combination of a UK investment trust and the cash-generative professional services operating business (IPS) continuing... ► Artikel lesen | ||
29.02. | Freelancer - Primed for margin expansion | 176 | Freelancer's FY23 results marked a key milestone as the group moved to positive operating EBITDA. Profitability was driven by lower opex than we anticipated as gross marketplace volume (GMV) and revenue... ► Artikel lesen | ||
29.02. | Actinogen Medical - Pressing forward with Xanamem | 191 | Having shown cognitive activity in prior trials, Actinogen began its XanaMIA Phase IIb study of lead candidate Xanamem in patients with cognitive impairment (CI) associated with mild-to-moderate Alzheimer's... ► Artikel lesen | ||
28.02. | OSE Immunotherapeutics - Confidence boost with AbbVie partnership | 420 | OSE Immunotherapeutics has announced a global licence and collaboration agreement with AbbVie to develop OSE-230, a novel monoclonal antibody, for the treatment of chronic and severe inflammation. The... ► Artikel lesen | ||
27.02. | Pan American Silver - FY23 results: Follow the cash flow | 705 | Pan American Silver (PAAS) has released its FY23 financial results, which are in line with our estimates at the EBITDA level, an encouraging outcome given the operationally challenging year. While the... ► Artikel lesen | ||
27.02. | CLIQ Digital - Steady progress and share buyback announced | 448 | CLIQ Digital showed robust revenue and profit growth in FY23 despite a more challenging backdrop. Revenue was below management guidance and Edison estimates, but profits were in line. Margins dipped... ► Artikel lesen | ||
27.02. | OSE Immunotherapeutics - Encouraging OSE-279 clinical update | 165 | At the 2024 ESMO Targeted Anticancer Therapies Congress, OSE Immunotherapeutics (OSE) presented encouraging interim results from the Phase I/II dose escalation and expansion study for OSE-279, its anti-PD1... ► Artikel lesen | ||
27.02. | Immix Biopharma - 2023 recap with a preview of active year ahead | 237 | Immix has shared a 12-month recap, capturing key clinical and regulatory events from 2023, setting the stage for an active 2024. Its lead CAR-T asset (NXC-201) is a B-cell maturation antigen (BCMA)... ► Artikel lesen | ||
26.02. | Sylvania Platinum - Sluggish PGM prices affect forecasts | 302 | Sylvania's Q224 and H124 results were overshadowed by a lower PGM basket price, which resulted in a 10% reduction in revenue. With the delay in the PGM price recovery we expected, we have pared back... ► Artikel lesen |